NCT01974973撤回1 期
Open Label Study of Autologous Bone Marrow Mononuclear Cells in Autism Spectrum Disorders
适应症
干预措施
试验速览
- 阶段
- 1 期
- 状态
- 撤回
- 试验地点
- 2
- 主要终点
- Improvement in the scales for Autism spectrum disorders
研究概览
简要总结
The purpose of this study was to study the effect of stem cell therapy on common symptoms in patients with autism spectrum disorders
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 6 Months 至 40 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed cases of any type of autism spectrum disorders
- •age above 6 months
排除标准
- •presence of acute infections such as Human immunodeficiency virus/Hepatitis B Virus/Hepatitis C Virus
- •malignancies
- •bleeding tendencies
- •pneumonia
- •renal failure
- •severe liver dysfunction
- •severe anemia [Hemoglobin < 8]
- •any bone marrow disorder
- •space occupying lesion in brain
- •other acute medical conditions such as respiratory infection and pyrexia
研究组 & 干预措施
Stem cell
Experimental
autologous bone marrow mononuclear cell transplantation
干预措施: Autologous bone marrow mononuclear cell transplantation (Procedure)
结局指标
主要结局
Improvement in the scales for Autism spectrum disorders
时间窗: Six months
次要结局
- Positron Emission Tomography- computed tomography to study change in brain metabolism(six months)
研究者
研究点 (2)
Loading locations...
相似试验
撤回
1 期
Stem Cell Therapy in Traumatic Brain InjuryTraumatic Brain InjuryNCT02028104Neurogen Brain and Spine Institute
撤回
2 期
Stem Cell Therapy in Spinal Cord InjurySpinal Cord InjuryNCT02009124Neurogen Brain and Spine Institute
撤回
1 期
Stem Cell Therapy for Cerebral PalsyCerebral PalsyNCT01978821Neurogen Brain and Spine Institute
撤回
1 期
Safety and Efficacy of Autologous Stem Cell Therapy in Chronic StrokeCerebrovascular AccidentNCT02065778Neurogen Brain and Spine Institute
撤回
1 期
Safety and Efficacy of Stem Cell Therapy in Spinal Cord InjurySpinal Cord InjuryNCT02027246Neurogen Brain and Spine Institute